- Forums
- ASX - By Stock
- MSB
- Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial
Ann: DSMB Analysis Recommends to Continue P3 COVID-19 ARDS Trial, page-2
-
-
- There are more pages in this discussion • 391 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
-0.050(4.69%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.04 | $1.04 | $1.00 | $1.588M | 1.555M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
16 | 26831 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 74249 | 18 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
16 | 82579 | 1.010 |
8 | 112007 | 1.005 |
18 | 140347 | 1.000 |
6 | 427848 | 0.995 |
7 | 55275 | 0.990 |
Price($) | Vol. | No. |
---|---|---|
1.015 | 11111 | 14 |
1.020 | 95350 | 13 |
1.025 | 68051 | 11 |
1.030 | 69290 | 8 |
1.035 | 3274 | 2 |
Last trade - 11.37am 04/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |